Compass Therapeutics, Inc.
CMPX
Revenue
0.00
0.000.00%
-Assets
155.61M
▼-5.53M▼-3.43%
3 Months ChangeLiabilities
9.51M
▲5.43M▲132.90%
3 Months ChangeFree Cash Flow
-12.23M
▼-4.09M▼-50.31%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001171843-24-004670
2024-08-12
Form 8-K
ID: 0001171843-24-004669
2024-06-17
Form 8-K
ID: 0001171843-24-003463
2024-05-28
Form 8-K
ID: 0001171843-24-003129
2024-05-13
Form 10-Q
ID: 0001171843-24-002785
2024-05-13
Form 8-K
ID: 0001171843-24-002784
2024-04-25
Form 8-K
ID: 0001171843-24-002220
2024-03-21
Form 8-K
ID: 0001171843-24-001515
2024-01-09
Form 8-K
ID: 0001171843-24-000164
2024-01-05
Form 8-K
ID: 0001171843-24-000082